Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

52°
- Poteau, OK (74953)
  Today
  
  Partly cloudy. High 67F. Winds light and variable..
  
  Tonight
  
  Some clouds this evening will give way to mainly clear skies overnight. Low 38F. Winds light and variable.
  
  Updated: February 11, 2026 @ 9:28 am
- Full Forecast

Site search

Home
News
Sports
Obituaries
Photos
PDN E-Edition
Classifieds
- Place an ad
Antlers American E-Edition
Archives
Best of 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

5.460 -0.170 (-3.02%)

Streaming Delayed Price Updated: 11:00 AM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bicycle Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Bicycle Therapeutics to Present End of Dose Escalation Data from Ongoing Phase I/II Study of BT8009 at the 2023 ASCO Genitourinary (GU) Cancers Symposium

January 11, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer

January 04, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Present Five Posters Highlighting Preclinical Data from its Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) Programs at the SITC 37th Annual Meeting

November 10, 2022

From Bicycle Therapeutics

Via Business Wire

Recap: Bicycle Therapeutics Q3 Earnings ↗

November 03, 2022

Bicycle Therapeutics (NASDAQ:BCYC) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Looking Into Bicycle Therapeutics's Return On Capital Employed ↗

November 23, 2022

Via Benzinga

Expert Ratings for Bicycle Therapeutics ↗

August 22, 2022

Within the last quarter, Bicycle Therapeutics (NASDAQ:BCYC) has observed the following analyst ratings:

Via Benzinga

Bicycle Therapeutics Announces First Patient Dosed in BT8009 Phase II Expansion Cohorts and Provides Program Update

November 08, 2022

From Bicycle Therapeutics

Via Business Wire

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

November 04, 2022

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 03, 2022

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Publication of Article in the Journal of Medicinal Chemistry Highlighting Preclinical Data from BT8009 Program

October 10, 2022

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT8009 Program in Molecular Cancer Therapeutics

September 19, 2022

From Bicycle Therapeutics plc

Via Business Wire

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗

September 07, 2022

Via Benzinga

Bicycle Therapeutics Announces BT5528 Phase I Dose Escalation Results in Patients with Advanced Solid Tumors

September 07, 2022

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

September 06, 2022

From Bicycle Therapeutics plc

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2022 ↗

August 31, 2022

Upgrades

Via Benzinga

Looking Into Bicycle Therapeutics's Return On Capital Employed ↗

August 22, 2022

According to data from Benzinga Pro, during Q2, Bicycle Therapeutics's (NASDAQ:BCYC) reported sales totaled $4.38 million. Despite a 2.67% increase in earnings, the company posted a loss of $26.83...

Via Benzinga

Bicycle Therapeutics: Q2 Earnings Insights ↗

August 04, 2022

Bicycle Therapeutics (NASDAQ:BCYC) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Bicycle Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 04, 2022

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Publication of Article in Bioconjugate Chemistry, Describing an Extension of its Proprietary Technology Platform Based on Bicyclic Peptides

August 02, 2022

From Bicycle Therapeutics plc

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022 ↗

July 28, 2022

Via Benzinga

Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal of Medicinal Chemistry

July 12, 2022

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration

July 12, 2022

From Bicycle Therapeutics plc

Via Business Wire

Where Bicycle Therapeutics Stands With Analysts ↗

July 06, 2022

Over the past 3 months, 5 analysts have published their opinion on Bicycle Therapeutics (NASDAQ:BCYC) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 24, 2022

Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 16.4% to $0.89 during Friday's pre-market session. The market value of their outstanding shares is at $47.6 million. As per the press...

Via Benzinga

Bicycle Therapeutics Announces First Patient Dosed in Expansion Cohorts of Phase I/II Trial of Bicycle® Toxin Conjugate BT5528 in Patients with Advanced Solid Tumors Associated with EphA2 Expression

June 08, 2022

From Bicycle Therapeutics plc

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

June 06, 2022

Monday's session saw 84 companies set new 52-week lows.

Via Benzinga

Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference

June 01, 2022

From Bicycle Therapeutics

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

Bicycle Therapeutics's Return On Capital Employed Overview ↗

May 27, 2022

Benzinga Pro data, Bicycle Therapeutics (NASDAQ:BCYC) reported Q1 sales of $3.86 million. Earnings fell to a loss of $27.56 million, resulting in a 52.82% decrease from last quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Poteau Daily News

PoteauDailyNews.com
804 N. Broadway
Poteau, OK 74953
Phone: 918-647-3188
Email: circulation@poteaudailynews.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Poteau, OK (74953)

Today

Tonight

Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

All News about Bicycle Therapeutics plc - American Depositary Shares

Sections

Services

Poteau Daily News